- Home
- Publications
- Publication Search
- Publication Details
Title
CD47 as a promising therapeutic target in oncology
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-22
DOI
10.3389/fimmu.2022.757480
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy
- (2022) Huanpeng Chen et al. Journal for ImmunoTherapy of Cancer
- Bispecific antibodies for immune cell retargeting against cancer
- (2022) Rebecca P Chen et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Recent Advances of Tumor Therapy Based on the CD47-SIRPα Axis
- (2022) Yuchen Wang et al. MOLECULAR PHARMACEUTICS
- QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment
- (2022) Kaspar Bresser et al. OncoImmunology
- Selective CD47 targeting with a bispecific antibody
- (2021) Walter Ferlin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A bispecific antibody targeting GPC3 and CD47 induced enhanced antitumor efficacy against dual antigen-expressing HCC
- (2021) Kaixin Du et al. MOLECULAR THERAPY
- An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
- (2021) Xinmin Wang et al. Cancer Medicine
- Structure of the human marker of self 5-transmembrane receptor CD47
- (2021) Gustavo Fenalti et al. Nature Communications
- Time-Programmed Delivery of Sorafenib and Anti-CD47 Antibody via a Double-Layer-Gel Matrix for Postsurgical Treatment of Breast Cancer
- (2021) Liping Huang et al. Nano-Micro Letters
- Lemzoparlimab, a Differentiated Anti-CD47 Antibody in Combination with Rituximab in Relapsed and Refractory Non-Hodgkin's Lymphoma: Initial Clinical Results
- (2021) Amitkumar Mehta et al. BLOOD
- AO-176, a Differentiated Clinical-Stage Anti-CD47 Antibody, Demonstrates Potent Anti-Tumor Activity across Multiple Preclinical Models of B Cell Neoplasms
- (2021) William Casey Wilson et al. BLOOD
- CD47 interactions with exportin-1 limit the targeting of m7G-modified RNAs to extracellular vesicles
- (2021) Sukhbir Kaur et al. Journal of Cell Communication and Signaling
- Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity
- (2021) Albin Jeanne et al. Cancers
- The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results
- (2020) David A Sallman et al. BLOOD
- Peptide analogues PKHB1 and 4N1K induce cell death through CD47‐independent mechanisms
- (2020) Pascal Leclair et al. CANCER SCIENCE
- Neoadjuvant checkpoint blockade for cancer immunotherapy
- (2020) Suzanne L. Topalian et al. SCIENCE
- Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential
- (2020) Linlin Ma et al. JOURNAL OF NANOBIOTECHNOLOGY
- A phase I study of ALX148, a CD47 blocker, in combination with standard anticancer antibodies and chemotherapy regimens in patients with advanced malignancy.
- (2020) Laura Quan Man Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
- (2020) Christina A. von Roemeling et al. Nature Communications
- Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection
- (2020) Lamin B. Cham et al. Cell Reports
- CD47: the next checkpoint target for cancer immunotherapy
- (2020) Ridong Feng et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Nanoscale Metal–Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy
- (2020) Kaiyuan Ni et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
- (2020) Tobias Bald et al. NATURE IMMUNOLOGY
- Targeting macrophage checkpoint inhibitor SIRPα for anticancer therapy
- (2020) Jie Liu et al. JCI Insight
- CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
- (2020) Hongfei Wang et al. Journal for ImmunoTherapy of Cancer
- Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy
- (2019) Meike E. W. Logtenberg et al. NATURE MEDICINE
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors
- (2019) Thomas W. Miller et al. PLoS One
- Increased lymphocyte activation and atherosclerosis in CD47-deficient mice
- (2019) Daniel Engelbertsen et al. Scientific Reports
- Natural killer cell recruitment and activation are regulated by CD47 expression in the tumor microenvironment
- (2019) Pulak Ranjan Nath et al. Cancer Immunology Research
- Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis
- (2019) Pedro Rodríguez-Jiménez et al. Frontiers in Immunology
- Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools
- (2019) Sanae Ben Mkaddem et al. Frontiers in Immunology
- CD47: role in the immune system and application to cancer therapy
- (2019) Seyed Mohammad Gheibi Hayat et al. CELLULAR ONCOLOGY
- TJC4, a Differentiated Anti-CD47 Antibody with Novel Epitope and RBC Sparing Properties
- (2019) Zhen Meng et al. BLOOD
- Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology
- (2019) Karen A. Autio et al. CLINICAL CANCER RESEARCH
- Harnessing innate immunity in cancer therapy
- (2019) Olivier Demaria et al. NATURE
- Targeting Tumor Microenvironment by Small-Molecule Inhibitors
- (2019) Shangwei Zhong et al. Translational Oncology
- Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review
- (2018) Atlantis Russ et al. BLOOD REVIEWS
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy
- (2018) André Veillette et al. TRENDS IN IMMUNOLOGY
- Microglia Demonstrate Age-Dependent Interaction with Amyloid-β Fibrils
- (2018) Angela Marie Floden et al. JOURNAL OF ALZHEIMERS DISEASE
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Monoclonal anti-CD47 interference in red cell and platelet testing
- (2018) Randall W. Velliquette et al. TRANSFUSION
- CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus
- (2018) Pulak Ranjan Nath et al. Frontiers in Immunology
- Cancer immunotherapy targeting the CD47/SIRPα axis
- (2017) Kipp Weiskopf EUROPEAN JOURNAL OF CANCER
- A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
- (2017) Jérôme Stirnemann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies
- (2017) Elie Dheilly et al. MOLECULAR THERAPY
- SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin
- (2017) Jun Chen et al. NATURE
- Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy
- (2017) Hengfeng Yuan et al. Nature Nanotechnology
- Localized CD47 blockade enhances immunotherapy for murine melanoma
- (2017) Jessica R. Ingram et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry
- (2017) Hongjuan Zhao et al. Clinical Epigenetics
- What Else Can CD39 Tell Us?
- (2017) Hai Zhao et al. Frontiers in Immunology
- Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor
- (2017) Elizabeth L. McMichael et al. OncoImmunology
- TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
- (2016) Penka S. Petrova et al. CLINICAL CANCER RESEARCH
- CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus
- (2016) Young-Tae Lee et al. JOURNAL OF VIROLOGY
- Designer exosomes as next-generation cancer immunotherapy
- (2016) Brandon M. Bell et al. Nanomedicine-Nanotechnology Biology and Medicine
- CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
- (2016) Yoko Kojima et al. NATURE
- Upregulation of CD47 in Regulatory T Cells in Atopic Dermatitis
- (2016) Nara Lee et al. YONSEI MEDICAL JOURNAL
- CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis
- (2016) Lu Gao et al. Oncotarget
- RRx-001, an epigenetic-based radio- and chemosensitizer, has vascular normalizing effects on SCCVII and U87 tumors
- (2016) Bryan Oronsky et al. Clinical Epigenetics
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
- (2015) Jie Liu et al. PLoS One
- CD300b regulates the phagocytosis of apoptotic cells via phosphatidylserine recognition
- (2014) Y Murakami et al. CELL DEATH AND DIFFERENTIATION
- Gamma-delta t-cell lymphomas
- (2014) Marco Foppoli et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Cutting Edge: CD47 Controls the In Vivo Proliferation and Homeostasis of Peripheral CD4+CD25+Foxp3+ Regulatory T Cells That Express CD103
- (2014) V. Q. Van et al. JOURNAL OF IMMUNOLOGY
- CD47 Expression on T Cell Is a Self-Control Negative Regulator of Type 1 Immune Response
- (2014) S. Bouguermouh et al. JOURNAL OF IMMUNOLOGY
- CD47-Independent Effects Mediated by the TSP-Derived 4N1K Peptide
- (2014) Pascal Leclair et al. PLoS One
- The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
- (2013) A. Neil Barclay et al. Annual Review of Immunology
- CD47 plays a critical role in T-cell recruitment by regulation of LFA-1 and VLA-4 integrin adhesive functions
- (2013) Veronica Azcutia et al. MOLECULAR BIOLOGY OF THE CELL
- Combination Immune Therapies to Enhance Anti-Tumor Responses by NK Cells
- (2013) Ashley Mentlik James et al. Frontiers in Immunology
- Is targeting of CD47-SIRP enough for treating hematopoietic malignancy?
- (2012) X. W. Zhao et al. BLOOD
- Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells
- (2012) V. R. Simhadri et al. BLOOD
- CD47 functions as a molecular switch for erythrocyte phagocytosis
- (2012) P. Burger et al. BLOOD
- CD47high Expression on CD4 Effectors Identifies Functional Long-Lived Memory T Cell Progenitors
- (2012) V. Q. Van et al. JOURNAL OF IMMUNOLOGY
- Recruitment of Natural Killer Cells in Advanced Stages of Endogenously Arising B-cell Lymphoma
- (2012) Margarethe Przewoznik et al. JOURNAL OF IMMUNOTHERAPY
- On the mechanism of CD47 targeting in cancer
- (2012) X. W. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
- (2011) M. P. Chao et al. BLOOD
- CD47 applies the brakes to angiogenesis via vascular endothelial growth factor receptor-2
- (2011) Sukhbir Kaur et al. CELL CYCLE
- CD47-signal regulatory protein- (SIRP ) interactions form a barrier for antibody-mediated tumor cell destruction
- (2011) X. W. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis
- (2010) Daniela Bratosin et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Nanomedicine
- (2010) Betty Y.S. Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
- (2010) M. P. Chao et al. Science Translational Medicine
- Macrophages as mediators of tumor immunosurveillance
- (2010) Siddhartha Jaiswal et al. TRENDS IN IMMUNOLOGY
- CD47 promotes both phosphatidylserine-independent and phosphatidylserine-dependent phagocytosis of apoptotic murine thymocytes by non-activated macrophages
- (2009) Anna Nilsson et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death
- (2009) T R Burton et al. CELL DEATH AND DIFFERENTIATION
- CD47 on experimentally senescent murine RBCs inhibits phagocytosis following Fc receptor-mediated but not scavenger receptor-mediated recognition by macrophages
- (2008) M. Olsson et al. BLOOD
- Endothelial CD47 interaction with SIRP is required for human T-cell transendothelial migration under shear flow conditions in vitro
- (2008) M. Stefanidakis et al. BLOOD
- Biological Research in the Evolution of Cancer Surgery: A Personal Perspective
- (2008) B. Fisher CANCER RESEARCH
- CD47 in the Immune Response: Role of Thrombospondin and SIRP-α Reverse Signaling
- (2008) Marika Sarfati et al. CURRENT DRUG TARGETS
- Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses
- (2008) Jeff S. Isenberg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells
- (2008) Richard K. Tsai et al. JOURNAL OF CELL BIOLOGY
- Trans-endocytosis of CD47 and SHPS-1 and its role in regulation of the CD47-SHPS-1 system
- (2008) S. Kusakari et al. JOURNAL OF CELL SCIENCE
- Paired Receptor Specificity Explained by Structures of Signal Regulatory Proteins Alone and Complexed with CD47
- (2008) Deborah Hatherley et al. MOLECULAR CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search